Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 15 → 16·19:49, 5 Aug 2025
Difference between revision 15 and revision 16 of Qingdao Saber Technology Pharmaceutical. 3 lines changed; the page grew by 357 bytes.
| Revision 15 — 02:29, 1 Aug 2025 BatchNumberBede (talk) add citation 4,905 bytes ±0 | Revision 16 — 19:49, 5 Aug 2025 DrTitration (talk) fix category — parent was wrong 5,262 bytes +357 | ||
|---|---|---|---|
| 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance. Water figures have appeared inconsistently across the submitted set.{{r|reports}} Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines. | 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance. Water figures have appeared inconsistently across the submitted set.{{r|reports}} Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines. |
| 31 | 31 | ||
| + | 32 | No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r|selfpub,gmp}} | |
| + | 33 | ||
| 32 | == References == | 34 | == References == |
| 33 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 38 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 39 | 42 | ||
| 40 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} | 43 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} |